Reply to A. Pfob et al

Nicholas Meti¹, Ali Sadeghi-Naini¹, William T Tran¹

Affiliations

Affiliation

¹ Nicholas Meti, MD, Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Ali Sadeghi-Naini, PhD, Department of Electrical Engineering and Computer Science, Lassonde School of Engineering, York University, Toronto, Ontario, Canada, Department of Radiation Oncology, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; and William T. Tran, MRT(T), MSc, PhD, Department of Radiation Oncology, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada, Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.

PMID: 34110932
DOI: 10.1200/CCI.21.00059

Comment

Reply to A. Pfob et al

Nicholas Meti et al. JCO Clin Cancer Inform. 2021 Jun.

. 2021 Jun:5:656-657.

doi: 10.1200/CCI.21.00059.

Authors

Nicholas Meti¹, Ali Sadeghi-Naini¹, William T Tran¹

Affiliation

¹ Nicholas Meti, MD, Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Ali Sadeghi-Naini, PhD, Department of Electrical Engineering and Computer Science, Lassonde School of Engineering, York University, Toronto, Ontario, Canada, Department of Radiation Oncology, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada; and William T. Tran, MRT(T), MSc, PhD, Department of Radiation Oncology, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada, Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.

PMID: 34110932
DOI: 10.1200/CCI.21.00059

No abstract available

PubMed Disclaimer

Conflict of interest statement

Ali Sadeghi-NainiResearch Funding: ElektaPatents, Royalties, Other Intellectual Property: I have two patents on application of quantitative ultrasound imaging for tissue characterization and therapy response monitoringNo other potential conflicts of interest were reported.

Comment on

Machine Learning Frameworks to Predict Neoadjuvant Chemotherapy Response in Breast Cancer Using Clinical and Pathological Features.
Meti N, Saednia K, Lagree A, Tabbarah S, Mohebpour M, Kiss A, Lu FI, Slodkowska E, Gandhi S, Jerzak KJ, Fleshner L, Law E, Sadeghi-Naini A, Tran WT. Meti N, et al. JCO Clin Cancer Inform. 2021 Jan;5:66-80. doi: 10.1200/CCI.20.00078. JCO Clin Cancer Inform. 2021. PMID: 33439725
Response Prediction to Neoadjuvant Systemic Treatment in Breast Cancer-Yet Another Algorithm?
Pfob A, Sidey-Gibbons C, Heil J. Pfob A, et al. JCO Clin Cancer Inform. 2021 Jun;5:654-655. doi: 10.1200/CCI.21.00033. JCO Clin Cancer Inform. 2021. PMID: 34110930 No abstract available.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

CIHR/Canada

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to A. Pfob et al

Affiliation

Reply to A. Pfob et al

Authors

Affiliation

Conflict of interest statement

Comment on

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical